KRAS and pancreatic neoplasm: Our observations in A549 cells are in line with data on murine pancreatic cancer cells where Kras mutations reduce the fraction of ciliated cells, which is rescued by LY294002, an inhibitor which targets PI3K among many other kinases11,36,37.